Literature DB >> 27863290

Cardiorenal acute kidney injury: Epidemiology, presentation, causes, pathophysiology and treatment.

Luca Di Lullo1, Antonio Bellasi2, Domenico Russo3, Mario Cozzolino4, Claudio Ronco5.   

Abstract

Cardiovascular disease and major cardiovascular events represent main cause of death in both acute and chronic kidney disease patients. Kidney and heart failure are common and frequently co-exist; this organ - organ interaction, also called organ cross-talk led to well-known definition of cardiorenal syndrome (CRS). Here we'll describe cardiovascular involvement in patients with acute kidney injury (AKI). Also known as type-3 CRS or acute reno-cardiac CRS, it occurs when AKI contributes and/or precipitates development of acute cardiac injury. AKI may directly or indirectly produce an acute cardiac event and it can be associated to volume overload, metabolic acidosis and electrolytes disorders such as hyperkalemia and hypocalcemia; coronary artery disease, left ventricular dysfunction and fibrosis have been also described in patients with AKI with consequent direct negative effects on cardiac performance.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Biomarkers; Renal replacement therapy; Type-3 cardiorenal syndrome

Mesh:

Year:  2016        PMID: 27863290     DOI: 10.1016/j.ijcard.2016.11.156

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

1.  The AKI glossary.

Authors:  Antoine Schneider; Marlies Ostermann
Journal:  Intensive Care Med       Date:  2017-04-01       Impact factor: 17.440

Review 2.  Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management.

Authors:  Yingmei Zhang; Adam T Whaley-Connell; James R Sowers; Jun Ren
Journal:  Pharmacol Ther       Date:  2018-06-22       Impact factor: 12.310

3.  Polyethylene glycol capped gold nanoparticles ameliorate renal ischemia-reperfusion injury in diabetic mice through AMPK-Nrf2 signaling pathway.

Authors:  Hanan Saleh; Mohamed Salama; Rehab Mohamed Hussein
Journal:  Environ Sci Pollut Res Int       Date:  2022-06-10       Impact factor: 5.190

4.  Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet.

Authors:  Fabiane Valentini Francisqueti; Igor Otávio Minatel; Artur Junio Togneri Ferron; Silméia Garcia Zanati Bazan; Vanessa Dos Santos Silva; Jéssica Leite Garcia; Dijon Henrique Salomé de Campos; Ana Lúcia Ferreira; Fernando Moreto; Antonio Carlos Cicogna; Camila Renata Corrêa
Journal:  Nutrients       Date:  2017-11-29       Impact factor: 5.717

5.  RTA-408 Protects Kidney from Ischemia-Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene.

Authors:  Peng Han; Zhiqiang Qin; Jingyuan Tang; Zhen Xu; Ran Li; Xuping Jiang; Chengdi Yang; Qianwei Xing; Xiaokang Qi; Min Tang; Jiexiu Zhang; Baixin Shen; Wei Wang; Chao Qin; Wei Zhang
Journal:  Oxid Med Cell Longev       Date:  2017-12-24       Impact factor: 6.543

6.  Maresin 1 mitigates renal ischemia/reperfusion injury in mice via inhibition of the TLR4/MAPK/NF-κB pathways and activation of the Nrf2 pathway.

Authors:  Yun Qiu; Yichen Wu; Hongmei Zhao; Hong Sun; Sumin Gao
Journal:  Drug Des Devel Ther       Date:  2019-02-20       Impact factor: 4.162

7.  Change in the NT-proBNP/Mature BNP Molar Ratio Precedes Worsening Renal Function in Patients With Acute Heart Failure: A Novel Predictor Candidate for Cardiorenal Syndrome.

Authors:  Hiroyuki Takahama; Toshio Nishikimi; Seiji Takashio; Tomohiro Hayashi; Chiaki Nagai-Okatani; Takashi Asada; Akihiro Fujiwara; Yasuaki Nakagawa; Masashi Amano; Yasuhiro Hamatani; Atsushi Okada; Makoto Amaki; Takuya Hasegawa; Hideaki Kanzaki; Kunihiro Nishimura; Satoshi Yasuda; Kenji Kangawa; Toshihisa Anzai; Naoto Minamino; Chisato Izumi
Journal:  J Am Heart Assoc       Date:  2019-08-23       Impact factor: 5.501

8.  Grb2 Induces Cardiorenal Syndrome Type 3: Roles of IL-6, Cardiomyocyte Bioenergetics, and Akt/mTOR Pathway.

Authors:  Jin Wang; Xuefeng Sun; Xu Wang; Shaoyuan Cui; Ran Liu; Jiaona Liu; Bo Fu; Ming Gong; Conghui Wang; Yushen Shi; Qianqian Chen; Guangyan Cai; Xiangmei Chen
Journal:  Front Cell Dev Biol       Date:  2021-03-22

Review 9.  Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome.

Authors:  Shuqing Shi; Bingxuan Zhang; Yumeng Li; Xia Xu; Jiayu Lv; Qiulei Jia; Ruoning Chai; Wenjing Xue; Yuan Li; Yajiao Wang; Huaqin Wu; Qingqiao Song; Yuanhui Hu
Journal:  Front Cardiovasc Med       Date:  2022-02-25

10.  Expression changes of autophagy-related proteins in AKI patients treated with CRRT and their effects on prognosis of adult and elderly patients.

Authors:  Yang Zhang; Ling Wang; Lei Meng; Guang-Ke Cao; Yu-Liang Zhao; Yu Wu
Journal:  Immun Ageing       Date:  2018-10-03       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.